Synthetic Archaeosome Vaccines Containing Triglycosylarchaeols Can Provide Additive and Long-Lasting Immune Responses That Are Enhanced by Archaetidylserine
Figure 4
Antibody titres in sera of mice immunized with various archaeosome adjuvants. Peripheral blood was collected at 5.5 weeks, just prior to euthanizing mice for spleen removal (Figure 1). Each data point shown represents the titre in the serum from an individual mouse. Means were significantly higher for the OVA-PGP archaeosome vaccinated group () compared to all groups except for Gentiotriosyl-A/Maltotriosyl-A/Mannotriosyl-A/PGP ().
